Family Medicine Doctors in Hillsboro, OR Accepting Medicare

89 Family Medicine doctors found. Showing 81 - 89

Gabrielle A Hendel, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 10670 Ne Cornell Rd Ste 101, Hillsboro, OR 97124 Phone: 503-216-9360

John Kingman, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 18610 Nw Cornell Rd, Suite 300, Hillsboro, OR 97124 Phone: 503-216-9300    Fax: 503-216-9363

Kim M Heydon, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 5555 Ne Elam Young Pkwy, Hillsboro, OR 97124 Phone: 503-216-1600    Fax: 503-216-1610

Hina Ahmad Khan, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 18610 Nw Cornell Rd Ste 300, Hillsboro, OR 97124 Phone: 503-216-9300    Fax: 503-216-9339

Dr. Daniel M Jarman-miller, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 7545 Se Tualatin Valley Hwy, Hillsboro, OR 97123 Phone: 503-681-4223

Dr. Peter E Hoffman, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 900 Se Oak St, Suite 202, Hillsboro, OR 97123 Phone: 503-640-3724    Fax: 503-648-8982

Elizabeth Uno, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 226 Se 8th Ave, Hillsboro, OR 97123 Phone: 503-601-7400    Fax: 503-601-7311

Mrs. Kristen Elizabeth Flemmer, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 100 Sw Baseline St, Hillsboro, OR 97123 Phone: 503-681-4273    Fax: 503-681-1953

Amelia Dawn Carr, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 7529 Se Tualatin Valley Hwy, Hillsboro, OR 97123 Phone: 503-681-4240

News Archive

Overall incidence of serious, highly drug-resistant group of bacteria relatively low in 2012-2013

The overall incidence in 2012-2013 was relatively low of a serious, highly drug-resistant group of bacteria (Carbapenem-resistant Enterobacteriaceae [CRE]) that are an important cause for health-care associated infections, according to a study published online by JAMA. Most CRE cases were associated with prior hospitalizations and discharge to long-term care settings.

Millennium and Takeda initiate TAK-700 Phase III clinical trial in advanced prostate cancer

Millennium: The Takeda Oncology Company with its parent company Takeda Pharmaceutical Company Limited today announced the initiation of a Phase III clinical trial for TAK-700 in the U.S. in patients with advanced prostate cancer. TAK-700 is a selective, oral, non-steroidal androgen synthesis inhibitor that in preclinical studies has been shown to selectively bind to and inhibit the enzyme 17,20 lyase in both the testes and adrenal glands.

FDA releases latest listing of consumer health information updates

The U.S. Food and Drug Administration today released its latest listing of consumer health information updates. All articles can be accessed from the agency's Web page for consumers at http://www.fda.gov/ForConsumers/default.htm.

IPD connector outperforms negative pressure, split-septum needleless IV connector

InVision-Plus with Neutral Advantage Technology outperformed a negative pressure, split-septum needleless IV connector in a prospective study that examined the association of different IV connector types with catheter-related bloodstream infection (CR-BSI) rates.

Fatty molecules which induce sleep may help with diagnosing Alzheimer's

A new study published today in the journal Alzheimer's & Dementia: The Journal of the Alzheimer's Association, has found that a particular class of molecules may help with diagnosing Alzheimer's Disease.

Read more Medical News

› Verified 7 days ago

• 1
• 2
• 3
• 4
• 5(current)